Sara Raponi

988 total citations
24 papers, 626 citations indexed

About

Sara Raponi is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Sara Raponi has authored 24 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 16 papers in Pathology and Forensic Medicine and 12 papers in Immunology. Recurrent topics in Sara Raponi's work include Chronic Lymphocytic Leukemia Research (18 papers), Lymphoma Diagnosis and Treatment (16 papers) and Immunodeficiency and Autoimmune Disorders (10 papers). Sara Raponi is often cited by papers focused on Chronic Lymphocytic Leukemia Research (18 papers), Lymphoma Diagnosis and Treatment (16 papers) and Immunodeficiency and Autoimmune Disorders (10 papers). Sara Raponi collaborates with scholars based in Italy, United States and Switzerland. Sara Raponi's co-authors include Robin Foà, Anna Guarini, Maria Stefania De Propris, Maria Laura Milani, Anna Guarini, Loredana Elia, Antonella Vitale, M. S. De Propris, Giovanni Pizzolo and Omar Perbellini and has published in prestigious journals such as Blood, British Journal of Haematology and Leukemia.

In The Last Decade

Sara Raponi

24 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Raponi Italy 15 252 244 231 225 215 24 626
A. W. Langerak Netherlands 9 87 0.3× 116 0.5× 116 0.5× 169 0.8× 125 0.6× 13 462
Beatrice Del Moro Italy 9 301 1.2× 123 0.5× 156 0.7× 495 2.2× 183 0.9× 10 776
Mary Browning United States 9 329 1.3× 78 0.3× 197 0.9× 94 0.4× 322 1.5× 17 461
A. Raghavachar Germany 9 155 0.6× 104 0.4× 211 0.9× 284 1.3× 104 0.5× 14 564
Sameh Gaballa United States 12 73 0.3× 169 0.7× 98 0.4× 269 1.2× 87 0.4× 55 413
M C López-Berges Spain 13 169 0.7× 100 0.4× 109 0.5× 606 2.7× 123 0.6× 21 741
MJ Keating United States 6 452 1.8× 145 0.6× 203 0.9× 181 0.8× 272 1.3× 9 641
A.M. Ford United Kingdom 8 94 0.4× 125 0.5× 215 0.9× 133 0.6× 88 0.4× 10 448
Carol Burian United States 9 605 2.4× 241 1.0× 303 1.3× 58 0.3× 418 1.9× 16 799
Lynn Savoie Canada 11 144 0.6× 170 0.7× 50 0.2× 298 1.3× 97 0.5× 25 523

Countries citing papers authored by Sara Raponi

Since Specialization
Citations

This map shows the geographic impact of Sara Raponi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Raponi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Raponi more than expected).

Fields of papers citing papers by Sara Raponi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Raponi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Raponi. The network helps show where Sara Raponi may publish in the future.

Co-authorship network of co-authors of Sara Raponi

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Raponi. A scholar is included among the top collaborators of Sara Raponi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Raponi. Sara Raponi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rigolin, Gian Matteo, Alice Traversa, Viviana Caputo, et al.. (2023). Additional lesions identified by genomic microarrays are associated with an inferior outcome in low‐risk chronic lymphocytic leukaemia patients. British Journal of Haematology. 202(5). 953–959. 1 indexed citations
2.
Raponi, Sara, Luca Vincenzo Cappelli, Caterina Ilari, et al.. (2021). Treatment with ibrutinib does not induce a <I>TP53</I> clonal evolution in chronic lymphocytic leukemia. Haematologica. 107(1). 334–337. 4 indexed citations
3.
Mauro, Francesca Romana, Diana Giannarelli, Clementina Maria Galluzzo, et al.. (2020). Response to the conjugate pneumococcal vaccine (PCV13) in patients with chronic lymphocytic leukemia (CLL). Leukemia. 35(3). 737–746. 51 indexed citations
4.
Raponi, Sara, Caterina Ilari, Irene Della Starza, et al.. (2020). Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations. British Journal of Haematology. 189(5). 853–859. 15 indexed citations
5.
Giudice, Ilaria Del, Sara Raponi, Irene Della Starza, et al.. (2019). Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal?. Frontiers in Oncology. 9. 689–689. 39 indexed citations
6.
Guarini, Anna, Nadia Peragine, Monica Messina, et al.. (2018). Unravelling the suboptimal response of TP53‐mutated chronic lymphocytic leukaemia to ibrutinib. British Journal of Haematology. 184(3). 392–396. 5 indexed citations
7.
Mauro, Francesca Romana, Fortunato Morabito, Iolanda Donatella Vincelli, et al.. (2017). Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemia. Leukemia Research. 57. 65–71. 19 indexed citations
8.
Stefanizzi, Caterina, Sara Raponi, Federico Vozella, et al.. (2016). Independent prognostic impact of CD15 on complete remission achievement in patients with acute myeloid leukemia. Hematological Oncology. 35(4). 804–809. 5 indexed citations
9.
Marinelli, M, Caterina Ilari, Yi Xia, et al.. (2016). Immunoglobulin gene rearrangements in Chinese and Italian patients with chronic lymphocytic leukemia. Oncotarget. 7(15). 20520–20531. 30 indexed citations
10.
Chiaretti, Sabina, Monica Messina, Francesca Paoloni, et al.. (2015). CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalities. Leukemia Research. 41. 36–42. 35 indexed citations
11.
Giudice, Ilaria Del, M Marinelli, Jiguang Wang, et al.. (2015). Inter‐ and intra‐patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments. British Journal of Haematology. 172(3). 371–383. 15 indexed citations
12.
Breccia, Massimo, Caterina Stefanizzi, Sara Raponi, et al.. (2014). Negative prognostic value of CD34 antigen also if expressed on a small population of acute promyelocitic leukemia cells. Annals of Hematology. 93(11). 1819–1823. 15 indexed citations
13.
Torelli, G, Nadia Peragine, Sara Raponi, et al.. (2014). Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cells. Haematologica. 99(7). 1248–1254. 50 indexed citations
14.
Giudice, Ilaria Del, M Marinelli, Sara Raponi, et al.. (2014). BIRC3 disruption and Copy Number Aberrations in Chronic Lymphocytic Leukemia (CLL) Patients with 11q Deletion. Blood. 124(21). 3295–3295. 1 indexed citations
15.
Breccia, Massimo, Maria Stefania De Propris, Clara Minotti, et al.. (2013). Aberrant phenotypic expression of CD15 and CD56 identifies poor prognostic acute promyelocytic leukemia patients. Leukemia Research. 38(2). 194–197. 18 indexed citations
16.
Tavolaro, Simona, Nadia Peragine, Sabina Chiaretti, et al.. (2013). IgD cross-linking induces gene expression profiling changes and enhances apoptosis in chronic lymphocytic leukemia cells. Leukemia Research. 37(4). 455–462. 7 indexed citations
17.
Marinelli, M, Nadia Peragine, Valeria Di Maio, et al.. (2012). Identification of molecular and functional patterns of p53 alterations in chronic lymphocytic leukemia patients in different phases of the disease. Haematologica. 98(3). 371–375. 17 indexed citations
18.
Raponi, Sara, Maria Stefania De Propris, Maria Laura Milani, et al.. (2011). Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases. Leukemia & lymphoma. 52(6). 1098–1107. 164 indexed citations
19.
Propris, M. S. De, Sara Raponi, Daniela Diverio, et al.. (2011). High CD33 expression levels in acute myeloid leukemia cells carrying the nucleophosmin (NPM1) mutation. Haematologica. 96(10). 1548–1551. 69 indexed citations
20.
Raponi, Sara, M. S. De Propris, L Elia, et al.. (2009). An accurate and rapid flow cytometric diagnosis of BCR-ABL positive acute lymphoblastic leukemia. Haematologica. 94(12). 1767–1770. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. W. Langerak Breakdown of academic impact, for papers by Beatrice Del Moro Breakdown of academic impact, for papers by Mary Browning Breakdown of academic impact, for papers by A. Raghavachar Breakdown of academic impact, for papers by Sameh Gaballa Breakdown of academic impact, for papers by M C López-Berges Breakdown of academic impact, for papers by MJ Keating Breakdown of academic impact, for papers by A.M. Ford Breakdown of academic impact, for papers by Carol Burian Breakdown of academic impact, for papers by Lynn Savoie
Rankless by CCL
2026